Birt-Hogg-Dubé syndrome (BHD) is an uncommon autosomal dominant genodermatosis characterized by fibrofolliculomas and trichodiscomas on the face and neck with acrochordons in flexural areas. These skin signs serve as markers for internal disease, most importantly spontaneous pneumothoraces and renal cancers. BHD is caused by a mutation in a tumor suppressor gene. This gene encodes the protein folliculin (FLCN), important for normal functioning of the mammalian target of rapamycin (mTOR) signaling pathway.1
Case report
A 33-year-old man presented with multiple 1- to 3-mm firm, flesh-colored papules on the face (Fig 1, A); numerous, scattered 2- 3-mm white papules on the trunk; and a discrete, well-demarcated 6-mm periungual papule on the fourth digit of the right hand (Fig 1, B). The patient reported no history of trauma to the digit. Histology from one facial papule found an angiofibroma. Similar histology was noted from the periungual lesion (Fig 1, C). Analysis of 2 truncal papules showed fibrofolliculomas. A complete cutaneous examination found no shagreen patches, hypopigmented macules, or obvious tooth enamel pitting.
Fig 1.
A, Angiofibroma on left nasal ala. B, Periungual angiofibroma on fourth digit of right hand. C, Photomicrograph from periungual lesion displays stellate capillary-sized blood vessels embedded within a fibrous stroma typical of angiofibromas.
The patient also reported an extensive family history of facial papules in a pattern consistent with autosomal dominant inheritance. Two spontaneous pneumothoraces were reported in a paternal uncle and a single pneumothorax in that uncle's son (Fig 2). Gene sequence analysis of FLCN found a previously unreported deletion in the gene responsible for BHD in both our patient and his cousin. Subsequent genetic analysis of the proband found no mutations indicative of tuberous sclerosis complex (TS). No family history of renal tumors was reported.
Fig 2.
Patient pedigree consistent with autosomal dominant inheritance.
Discussion
This case and family history demonstrate the hereditary nature of BHD and its significant association with internal disease processes. Unique to this case is the presence of a Koenen's tumor (periungual angiofibroma). A PubMed search of the English-language literature failed to reveal a similar association.
Koenen's tumors are typically associated with TS. Whereas the typical facial papules of BHD consist of fibrofolliculomas and trichodiscomas, facial angiofibromas indistinguishable from those in TS have also been reported.2, 3 Likewise, there is a report of fibrofolliculomas typical of BHD in a patient with confirmed TS.4 Accordingly, significant cutaneous clinical overlap exists between BHD and TS.
Internal manifestations overlap as well. Both BHD and TS are associated with pulmonary cysts, renal cysts, and renal cancers. Recent case reports describe 2 BHD patients with seizures and a patient with a renal angiomyolipoma, both presentations typically associated with TS.3, 5
The similarities between BHD and TS extend beyond clinical presentation. FLCN and the TS proteins, hamartin and tuberin, appear to have different yet important roles in the mTOR pathway.1 BHD results in inhibition of the mTOR pathway. In contradistinction, TS results in mTOR activation. This finding suggests a new paradigm in which both inappropriately high and inappropriately low levels of mTOR activity can result in tumorigenesis.6
Multiple histologically different renal tumor types are associated with BHD. This finding suggests a 2-hit mechanism in which a second individual mutation, on the wild-type FLCN allele, is necessary for tumor promotion.7 In contrast, cutaneous fibrofolliculomas8 and lung cysts9 show retention of the wild-type allele, suggesting that other genetic mechanisms, such as haplodeficiency, play a role as well.
This case adds to the constellation of cutaneous manifestations of BHD and illustrates the overlap between BHD and TS. If overlapping features of BHD and TS are present, genetic testing is important to establish the correct diagnosis. Once the diagnosis is established, genetic counseling should be provided to the patient and family members.
Acknowledgments
The authors thank William Halley Ramsdell for editorial assistance in the preparation of this manuscript.
Footnotes
Funding sources: None.
Conflicts of interest: None declared.
References
- 1.Menko F.H., van Steensel M.A., Giraud S. Birt-Hogge-Dube Syndrome: diagnosis and management. Lancet Oncol. 2009;10(12):1199–1206. doi: 10.1016/S1470-2045(09)70188-3. [DOI] [PubMed] [Google Scholar]
- 2.Schaffer J.V., Gohara M.A., McNiff J.M. Multiple facial angiofibromas: a cutaneous manifestation of Birt-Hogg-Dube syndrome. J Am Acad Dermatol. 2005;53:108–111. doi: 10.1016/j.jaad.2004.11.021. [DOI] [PubMed] [Google Scholar]
- 3.Spring P., Fellman F., Giraud S. Syndrome of Birt-Hogg-Dube, a histopathological pitfall with similarities to tuberous sclerosis: a report of three cases. AmJ Dermatopath. 2013;35(2):241–245. doi: 10.1097/DAD.0b013e318259b593. [DOI] [PubMed] [Google Scholar]
- 4.Misago N., Narisawa Y. Fibrofolliculoma in a patient with tuberous sclerosis complex. Clin Exp Dermatol. 2009;38:892–894. doi: 10.1111/j.1365-2230.2008.03065.x. [DOI] [PubMed] [Google Scholar]
- 5.Byrne M., Mallipeddi R., Pichert G., Whittaker S. Birt-Hogg-Dubé syndrome with a renal angiomyolipoma: further evidence of a relationship between Birt-Hogg-Dubé syndrome and tuberous sclerosis complex. Australas J Dermatol. 2012;53(2):151–154. doi: 10.1111/j.1440-0960.2011.00738.x. [DOI] [PubMed] [Google Scholar]
- 6.Hartman T.R., Nicholas E., Klein-Szanto A. The role of Birt-Hogg-Dube protein in mTOR activation and renal tumorigenesis. Oncogene. 2009;28:1594–1604. doi: 10.1038/onc.2009.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Khoo S.K., Giraud S., Kahnoski K. Clinical and genetic studies of Birt-Hogg-Dube syndrome. J Med Genet. 2002;39:906–912. doi: 10.1136/jmg.39.12.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Van steensel M.A., Verstraeten V.L., Frank J. Novel mutations in the BHD gene and absence of loss of heterozygosity in fibrofolliculomas of Birt-Hogg-Dubé patients. J Invest Dermatol. 2007;127(3):588–593. doi: 10.1038/sj.jid.5700592. [DOI] [PubMed] [Google Scholar]
- 9.Koga S., Furuya M., Takahashi Y. Lung cysts in Birt-Hogg-Dube syndrome: histopathological characteristics and aberrant sequence repeats. Pathol Int. 2009;59:720–728. doi: 10.1111/j.1440-1827.2009.02434.x. [DOI] [PubMed] [Google Scholar]


